· Gerster,
M.,
Peker,
E.,
Nagel,
E.,
& Puntmann,
V.
O.
(2016).
Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients’ care. Expert review of cardiovascular therapy, 14(11),
1283-1295.
· Mavrogeni,
S.
I.,
Kitas,
G.
D.,
Dimitroulas,
T.,
Sfikakis,
P.
P.,
Seo,
P.,
Gabriel,
S.,
Lombardi,
M.
(2016).
Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. International journal of cardiology, 217,
135-148.
· Goh,
Y.
P.,
Naidoo,
P.,
& Ngian,
G.
S.
(2013).
Imaging of systemic lupus erythematosus.
Part I: CNS,
cardiovascular,
and thoracic manifestations. Clinical radiology, 68(2),
181-191.
· Ntusi NA,
Piechnik SK,
Francis JM,
Ferreira VM,
Rai AB,
Matthews PM,
Karamitsos,
TD.
(2014).
Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis–a clinical study using myocardial T1-mapping and extracellular volume quantification. Journal of Cardiovascular Magnetic Resonance, 16(1),
21.
· Tzelepis GE,
Kelekis NL,
Plastiras SC,
Mitseas P,
Economopoulos N,
Kampolis C,
Moutsopoulos,
HM.
(2007).
Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 56(11),
3827-3836.
· Huber AT,
Bravetti M,
Lamy J,
Bacoyannis T,
Roux C,
De Cesare A,
Cluzel P.
(2018).
Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping. Journal of cardiovascular magnetic resonance, 20(1),
11.